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Retinopathy in diabetic patients evaluated at a primary care 
clinic in Cape Town
Olivia Read, Colin Cook
To the Editor: Diabetic retinopathy is the fifth leading cause of 
global blindness, affecting an estimated 1.8 billion people and 
responsible for 4.8% of blindness.1  In South Africa, it is the 
third leading cause of blindness after cataract and glaucoma, 
and is responsible for 5% of blindness (0.04% of the total 
population).  Cataract and refractive error are prioritised for 
the first phase of Vision 2020 in South Africa, while strategies 
to deal with diabetic retinopathy are recommended as a 
priority for the second phase.2 These strategies will include 
provision of adequate screening and argon laser treatment.
The prevalence of diabetes differs in different population 
groups in South Africa. Among black and coloured South 
Africans, diabetes has risen from 3% to 12% over the past 10 
years.  Overall, the prevalence is conservatively estimated to be 
3 - 5% (30 000 - 50 000 per million population).2 The prevalence 
of retinopathy in people with diabetes is estimated to be 20% 
(6 000 - 10 000 per million population), and the prevalence of 
blindness among these is estimated to be 5% (300 - 500 blind 
per million population).2 
The objective of this study was to evaluate the retinopathy 
status of patients with diabetes seen at a primary care clinic in 
Cape Town and to assess the adequacy of the current diabetic 
screening programmes. 
Methods
Two hundred and forty-eight consecutive patients with type 
2 diabetes were seen at Robbie Nurock Day Hospital in Cape 
Town between 15 September 2005 and 21 November 2005.  An 
interview elicited the duration of their diabetes, and whether or 
not they had had previous fundoscopy.  Examination included 
best corrected visual acuity and undilated fundoscopy using 
a direct ophthalmoscope. If retinopathy was detected, or if 
the view was not adequate, fundoscopy was repeated with 
pupil dilatation. Retinopathy status was classified according 
to the Early Treatment of Diabetic Retinopathy Study (ETDRS) 
classification.3  
Results
The study population consisted of 124 (50%) black, 119 (48%) 
coloured and 5 (2%) white persons, and 1 Asian person.  
Gender distributions were 171 (69%) female and 77 (31%) male. 
Of these patients, 23.6% (95% confidence interval (CI) 18.3 
- 28.9%) had had previous fundal examination at some stage 
in their diabetic history, but only 5.2% (95% CI 2.4 - 8.0%) had 
had regular annual fundoscopy as recommended. It was found 
that 4.4% (95% CI 0.0 - 7.0%) had visual impairment (6/24 - 
6/60) or severe visual impairment (6/60 - 3/60) due to diabetic 
retinopathy. The prevalence of diabetic retinopathy was 32.3% 
(95% CI 5.4 - 12.4%), with 8.9% (95% CI 5.4 - 12.4%) having 
sight-threatening retinopathy requiring urgent referral to an 
ophthalmologist for laser treatment (Table I). Only 2% (95% 
CI 1.4 - 2.6%) had been previously assessed as needing laser 
treatment and were being followed up in a tertiary setting. 
It was also noted that diabetic patients frequently experience 
ocular disorders other than diabetic retinopathy (Table II).  
A prior Joslin Vision Network Protocol (JVN) study found 
that 25.9% of patients had abnormalities other than diabetic 
retinopathy requiring referral for a comprehensive eye exam.4  
Patients who were diagnosed with sight-threatening 
retinopathy and other serious ocular conditions were urgently 
referred, and these accounted for 11.3% of the sample size.  
Other patients with mild or moderate retinopathy and other 
ocular conditions such as cataract were also referred ‘non-
urgently’, and these accounted for 29% of the sample size (22% 
due to diabetes, and 7% due to other eye conditions). Of the 
total 248 patients, therefore, 40% required an ophthalmologist 
review. 
Ethnicity, age and gender did not appear to be associated 
independently with a greater degree of diabetic retinopathy; 
however, the sample size was too small to obtain statistically 
significant results.
Discussion
It is evident from these statistics that we are falling well 
short of the recommended screening protocols for diabetics.  
The advantages of adequate screening are paramount, both 
for the patient in question and economically.  Retinopathy 
diagnosed early, and followed closely, results in more timeous 
laser treatment, preventing complications of proliferative 
retinopathy, and most importantly, blindness. ‘Too little 
too late’ probably best summarises the reality of diabetic 
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retinopathy management generally in the public sector in 
South Africa.
It was found that there was a general lack of awareness 
among the diabetic patients with regard to the existence of 
diabetic eye disease, and the importance of screening.  Only 
10.4% of patients were aware that annual fundoscopy was a 
requirement.  This emphasises the importance of education as 
part of the screening process.  
Assuming a prevalence of 3 - 5%, there are 30 000 -  
50 000 people with diabetes in each health district of 1 million 
population who require annual screening fundoscopy. Forty 
per cent of the diabetic patients seen required referral to an 
ophthalmologist and possibly further intervention, a very 
significant figure considering that there are 47 day hospitals in 
Cape Town, and only 2 tertiary centres receiving referrals.  The 
ophthalmology departments in both these hospitals are already 
working well beyond capacity.  It would be unreasonable to 
believe that they would be able to cope with the further burden 
of referrals from day hospitals should a proper screening 
programme be implemented. It is essential that alternatives be 
found.  
The recommendation for the management of retinopathy in 
individual patients and for the Vision 2020 programme strategy 
for diabetic retinopathy is: (i) baseline fundoscopy at the initial 
diagnosis of diabetes; (ii) annual fundoscopy screening; (iii) 
on detection of retinopathy, referral to an ophthalmologist 
for follow-up; (iv) depending on the severity/grade of 
retinopathy, 3 - 6-monthly fundoscopy by the ophthalmologist; 
(v) panretinal laser treatment for severe non-proliferative 
retinopathy and proliferative retinopathy; and (vi) either focal 
or grid laser treatment for maculopathy.1 
Dilated indirect ophthalmoscopy coupled with 
biomicroscopy, and 7 standard field stereoscopic 30º fundus 
photography are both accepted methods for examining diabetic 
retinopathy.5  These methods are time consuming and require 
a degree of ophthalmological training to assess the fundus 
accurately.  Day hospitals are extremely busy, and medical 
officers generally do not stay beyond 6 months.  This does not 
allow enough time for adequate ophthalmological training and 
accurate screening.  
Another option for screening is to use a non-mydriatic 
fundus camera linked to a tele-ophthalmology facility, with 
the fundus photographs checked by an ophthalmologist 
at a central ophthalmology clinic or reading centre.6   The 
Western Cape health department has acquired a non-mydriatic 
camera and currently has a pilot project running at 3 of the 
day hospitals.  One ophthalmic technician has been trained 
to take the photos which will then be sent to a reading centre 
for assessment. An adequate recall system will obviously also 
be required for this to be successful.  An argon laser has also 
been acquired and placed at the Cape Town Technikon where 
panretinal and focal laser will be performed.
Assuming an annual incidence of 0.03% of macular oedema 
and 0.02% of proliferative retinopathy in a health district of  
1 million people, there would be 500 new cases requiring laser 
treatment each year.  If the time required to provide focal or 
grid macular laser treatment to 2 eyes is 1 hour and the time 
required to provide panretinal laser treatment to 2 eyes is  
2 hours, the total laser hours required in each health district  
of 1 million population is about 700 hours per year.  Assuming 
a 40-hour working week and a 50-week working year, it 
seems that 30% of the working time of 1 ophthalmologist in 
each district of 1 million might be taken up just doing laser 
treatment for diabetic retinopathy.  This is not feasible.  An 
option for providing the laser treatment is to train non-
ophthalmologist medical officers to administer the treatment.  
Table I. Findings on fundal examination
No. % (95% CI)
No retinopathy 168 67.7 (61.9 - 73.5)
Mild non-proliferative 
retinopathy
54 21.8 (16.7 - 26.9)
Moderate non-
proliferative 
retinopathy
4 1.6 (0.0 - 3.2)
Severe non-
proliferative 
retinopathy
1 0.4 (0.0 - 1.2)
Proliferative 
retinopathy
6 2.4 (0.5 - 4.3)
Clinically significant 
macula oedema 
(CSMO) + mild 
non-proliferative 
retinopathy
3 1.2 (0.0 - 2.6)
CSMO + moderate 
non- proliferative 
retinopathy
6 2.4 (0.5 - 4.3)
CSMO + severe 
non-proliferative 
retinopathy
9 1.2 (0.0 - 2.6)
CSMO + proliferative 
retinopathy
3 1.2 (0.0 - 2.6)
Table II. Other pathology diagnosed on fundoscopy 
     No.  % (95% CI)
Cataract       18                 7.3 (4.1 - 10.5)
Glaucoma – suspect        7                 2.8 (0.7 - 4.9)
Retinal detachment        4                 1.6 (0.0 - 3.2)
Maculopathy        3                 1.2 (0.0 - 2.6)
Retinal vein occlusion       2                  0.8 (0.0 - 1.9)
Unknown        4                  1.6 (0.0 - 3.2)
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This is visually demanding and tiring work, and it would 
not be possible for any one person to do this work for more 
than 2 - 4 hours each day.  The possibility is therefore for an 
argon laser machine in use for 15 - 20 hours each week in each 
health district, with the treatments being administered by a 
team of medical officers working 2 - 4-hour shifts, and with 
the machine receiving timeous and efficient servicing and 
maintenance to avoid down-time from breakages.
This cross-sectional study highlights the deficiencies 
that exist in the current screening and management of 
diabetic patients, and highlights the need to include diabetic 
retinopathy as a priority in our Vision 2020 programme.
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Health and demographic surveillance sites contribute 
population-based data on maternal deaths in rural areas
Renay Weiner, Stephen Tollman, Kathleen Kahn, Loveday Penn-Kekana
To the Editor: Maternal mortality remains an important public 
health challenge in South Africa despite government initiatives 
to monitor and reduce maternal deaths.1  In particular, the 
mandatory notification of maternal deaths, with rigorous 
investigation through the National Committee on Confidential 
Enquiries into Maternal Deaths, has been an important 
national intervention to quantify the problem and monitor 
trends.  However, this system of enquiry is fundamentally 
health service-based, and data are collected largely through 
record review and notification forms submitted from the health 
facility where the death occurred.2 The vital registration system 
offers another source of maternal death data, but reporting 
of deaths, particularly in rural under-resourced areas, is 
incomplete.  While death registration has increased nationally 
from 54% in 1990 to 89% in 2000, only 78% of deaths were  
registered in rural Limpopo province in 2002.3,4  In contrast, 
health and demographic surveillance sites (HDSSs), which 
collect household-level data on all births and deaths in a 
defined population, are able to identify maternal deaths that 
occur in the community. Moreover, this system provides an 
opportunity to interview those close to the deceased, using the 
verbal autopsy method, to gain an understanding of possible 
causes, as well as contributory and avoidable factors that led to 
the death.5  
The Agincourt HDSS, located in the rural north-east of 
South Africa, is 1 of 3 such sites in the country (Dikgale DSS, 
University of Limpopo, and Africa Centre DSS, University of 
KwaZulu-Natal, are the other 2 sites). A review of maternal 
deaths occurring at this site between 2000 and 2005 indicates 
that 6 of the 26 deaths occurred outside of the health system/
at home, and hence might have been missed by the existing 
notification system.  This is a much higher proportion than 
the 2.8% reported nationally, albeit for a different time period.6  
Given that women with least access to services are likely to 
be those whose deaths go undetected, the factors contributing 
to their deaths are likely also to go undocumented – and thus 
fail to inform local practice. Hence, the HDSS provides an 
additional source of data on maternal deaths that complements 
national facility-based data by offering a population-based 
perspective. High-quality data on maternal deaths from rural 
areas is especially important, given that these areas have the 
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highest burden of mortality and the least reliable information.7  
Health and demographic surveillance sites are able to capture 
this community experience effectively so that barriers to health 
service access, such as transport, finance and local culture, can 
be better understood and addressed in South Africa’s rural 
areas.  
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